A Study to Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED)

Organon

Status and phase: Completed; Phase 3

Conditions: Hyperlipidemia; Hypertriglyceridemia; Hypercholesterolemia

Treatments: Drug: ezetimibe (+) simvastatin

Study type: Interventional

Funder types: Industry

Identifiers

NCT00093899

2004_044

0653A-071

Details and patient eligibility

About

The purpose of this study is to assess the cholesterol lowering effects of an investigational drug in patients with mixed hyperlipidemia (high cholesterol and high triglycerides).

Enrollment: 611 patients

Sex: All

Ages: 18 to 79 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Men and women 18-79 years of age with high cholesterol and high triglycerides.

Exclusion criteria

• Individuals who do not meet specific cholesterol or triglyceride levels as required by the study.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind